-
Journal of Chromatographic Science Mar 2018A quantitative LC-MS/MS method has been developed for simultaneous determination of bacitracin A, bacitracin B, colistin A, colistin B and virginiamycin M1 in feed. This...
Analysis of Major Components of Bacitracin, Colistin and Virginiamycin in Feed Using Matrix Solid-phase Dispersion Extraction by Liquid Chromatography-electrospray Ionization Tandem Mass Spectrometry.
A quantitative LC-MS/MS method has been developed for simultaneous determination of bacitracin A, bacitracin B, colistin A, colistin B and virginiamycin M1 in feed. This rapid simple and effective extraction method was based on matrix solid-phase dispersion. Qualitative and quantitative analyses were performed by LC-ESI-MS/MS. CCβ of polypeptide antibiotics upon the method ranged from 9.6 to 15.8 μg kg-1 and 19.4 to 27.5 μg kg-1, respectively. The limit of quantification of polypeptide antibiotics was 25 μg kg-1 in feed samples. The recoveries of polypeptide antibiotics spiked in feed samples at a concentration range of 25-100 μg kg-1 were found above 75.9-87.9% with relative standard deviations within days less than 15.7% and between days less than 20.6%. This rapid and reliable method can be used to efficiently separate, characterize and quantify the residues of polypeptide antibiotics in feed with advantages of simple pretreatment and environmental friendly.
Topics: Animal Feed; Bacitracin; Chromatography, Liquid; Colistin; Drug Residues; Limit of Detection; Linear Models; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Virginiamycin
PubMed: 29244148
DOI: 10.1093/chromsci/bmx096 -
Gene Mar 2002Streptomyces virginiae produces -butyrolactone autoregulators (virginiae butanolide, VB), which control the biosynthesis of virginiamycin M1 and S. A 6.3-kb region...
Streptomyces virginiae produces -butyrolactone autoregulators (virginiae butanolide, VB), which control the biosynthesis of virginiamycin M1 and S. A 6.3-kb region downstream of the virginiamycin S (VS)-resistance operon in S. virginiae was sequenced, and four plausible open reading frames (ORFs) (visA, 1,260 bp; visB, 1,656 bp; visC, 888 bp; visD, 1209 bp) were identified. Homology analysis revealed significant similarities with enzymes involved in the biosynthesis of cyclopeptolide antibiotics: VisA (53% identity, 65% similarity) to -lysine 2-aminotransferase (NikC) of nikkomycin D biosynthesis, VisB (66% identity, 72% similarity) to 3-hydroxypicolinic acid:AMP ligase of pristinamycin I biosynthesis, VisC (48% identity, 59% similarity) to lysine cyclodeaminase of ascomycin biosynthesis, and VisD (43% identity, 56% similarity) to erythromycin C-22 hydroxylase of erythromycin biosynthesis. Northern blotting as well as high-resolution S1 analysis of the ORFs revealed that they were transcribed as two bicistronic transcripts, namely 3.0-kb visB-visA and another 2.7-kb visC-visD transcript, with promoters locating upstream of visB and visC, respectively. Transcription of the two operons was observed only 1 h after the VB production, which was 2 h before the virginiamycin production. Furthermore, prompt induction of the transcription was observed as a result of external VB addition, suggesting that the expression of the two operons was under the control of VB.
Topics: Ammonia-Lyases; Bacterial Proteins; Base Sequence; Cytochrome P-450 Enzyme System; DNA, Bacterial; Gene Order; Genes, Bacterial; Ligases; Molecular Sequence Data; Sequence Analysis, DNA; Streptomyces; Transaminases; Transcription Initiation Site; Transcription, Genetic; Virginiamycin
PubMed: 11943483
DOI: 10.1016/s0378-1119(02)00424-9 -
Poultry Science Dec 2005Shuttle programs involving dietary supplementation of mannanoligosaccharides (MOS) and virginiamycin (VM) were evaluated in turkeys by their effects on growth... (Randomized Controlled Trial)
Randomized Controlled Trial
Shuttle programs involving dietary supplementation of mannanoligosaccharides (MOS) and virginiamycin (VM) were evaluated in turkeys by their effects on growth performance, body weight uniformity, and carcass yield characteristics. Diets containing no growth promoter (control), VM (22 mg/kg), or a shuttle program (MOS-VM) of MOS (0 to 6 wk of age at 500 mg/ kg) and VM (6 to 14 wk of age at 22 mg/kg) were fed to Hybrid female turkeys. All diets were formulated to exceed NRC nutrient requirements. Each treatment was assigned to 8 replicate floor pens containing 20 birds that were reared from 1 to 98 d of age. Body weights and feed consumption were recorded at 3-wk intervals, and mortality and culled birds were recorded daily. At the conclusion of the trial, 2 birds per pen were randomly chosen for carcass yield analysis. Feeding VM alone significantly (P < 0.05) increased body weight compared with control fed birds during all periods. The MOS-VM shuttle program resulted in early growth depression for birds less than 3 wk of age, possibly influenced by an unplanned cold stress, but better growth than the nonmedicated control birds after 6 wk of age. Birds fed VM had superior (P < 0.05) feed conversion ratio from 0 to 3 wk, which persisted until 14 wk (P < 0.10). There were no treatment effects on overall feed consumption, uniformity, mortality, or cull rate. Processing yields or weight of various parts were also unaffected by treatment.
Topics: Aging; Animal Feed; Animals; Anti-Bacterial Agents; Diet; Dietary Supplements; Drug Administration Schedule; Female; Mannans; Turkeys; Virginiamycin; Weight Gain
PubMed: 16479957
DOI: 10.1093/ps/84.12.1967 -
The Analyst Jan 1989Standard additions experiments for chlortetracycline hydrochloride and virginiamycin at a ratio of 16:1 showed a positive bias for both the plate and turbidimetric...
Standard additions experiments for chlortetracycline hydrochloride and virginiamycin at a ratio of 16:1 showed a positive bias for both the plate and turbidimetric methods. The bias was eliminated by anion-exchange chromatography in both the presence and absence of feed components. When chlortetracycline and virginiamycin pre-mixes were used for fortification of laboratory-prepared feeds at chlortetracycline to virginiamycin ratios of 8 or 16:1, the recovery of virginiamycin, without treatment, was 93-100% using the plate assay and 181-236% with the turbidimetric method. The corresponding values obtained using anion-exchange chromatography were 89-99 and 85-91%, respectively. The anion-exchange technique is necessary if the turbidimetric method is used for the assay.
Topics: Animal Feed; Chlortetracycline; Chromatography, Ion Exchange; Virginiamycin
PubMed: 2496624
DOI: 10.1039/an9891400057 -
Veterinary Medicine, Small Animal... Nov 1972
Topics: Animals; Anti-Bacterial Agents; Dysentery; Swine; Swine Diseases; Virginiamycin
PubMed: 4564020
DOI: No ID Found -
The Journal of Biological Chemistry May 1984The two virginiamycin components VM and VS interact synergistically with bacterial ribosomes in vitro and in vivo. Ribosome affinity for virginiamycin S increases about...
The two virginiamycin components VM and VS interact synergistically with bacterial ribosomes in vitro and in vivo. Ribosome affinity for virginiamycin S increases about 10-fold upon incubation with virginiamycin M. This effect has been previously traced by spectrofluorimetric measurement based on the enhancement of virginiamycin S fluorescence upon its binding to the 50 S ribosomal subunit. In the present work the action of two virginiamycin S fluorescence quenchers, acrylamide and iodide, has been explored to gather information about the accessibility of ribosome-bound virginiamycin S and the variation of the accessibility level in the presence of virginiamycin M. Both acrylamide (non-ionized quencher) and iodide (ionized quencher) proved powerful quenchers of free virginiamycin S solutions. Since a comparable effect was obtained on 3- hydroxypicolinamide , the latter was indicated as the part of the molecule involved in the fluorescence effect. Fluorescence quenching by either agent was of the dynamic, i.e. collisional, type. Such an inference was based on the fact that these quenchers merely modified the emission spectrum (not the absorption spectrum), the bimolecular rate constant for the quenching process decreased linearly with the viscosity of the medium (static-type quenching is viscosity-independent), and that linear Stern-Volmer plots were obtained. The quenching ability of both agents underwent a sharp decrease in the presence of ribosomes; however, the Stern-Volmer equation was followed only in the case of acrylamide, whereas Lehrer 's relationship had to be applied in the case of iodide. When ribosomes were incubated with virginiamycin M, the fluorescence quenching ability of acrylamide and iodide was significantly reduced. Conclusions are as follows: a) the 3- hydroxypicolinyl residue of virginiamycin S is buried within an open well on the ribosome surface and is likely to be involved in the interaction with the binding site; b) the accessibility to the well is partly controlled by electrostatic forces; c) interaction of ribosomes with virginiamycin M entails a conformational change whereby the access to the well is reduced. These findings provide a molecular explanation for the previously observed increase of the association constant of virginiamycin S to ribosomes incubated with virginiamycin M which was found to be due to the decrease of the dissociation rate constant (the association rate constant remains practically the same).
Topics: Anti-Bacterial Agents; Escherichia coli; Kinetics; Ribosomes; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Virginiamycin
PubMed: 6427212
DOI: No ID Found -
Journal of Animal Science Jan 1995The effects of dietary virginiamycin level on performance and liver abscesses in feedlot cattle were evaluated in seven dose-response studies. Steers and heifers were...
The effects of dietary virginiamycin level on performance and liver abscesses in feedlot cattle were evaluated in seven dose-response studies. Steers and heifers were fed finishing diets ranging in energy content from 1.34 to 1.51 Mcal of NEg/kg of DM. In all studies, virginiamycin added to the diet improved average daily gain and(or) feed conversion, with no substantial effect on dry matter intake. Pooled analyses of four studies providing virginiamycin at 11.0, 19.3, and 27.6 mg/kg of DM in the complete diet indicated that growth and feed conversion were linearly improved (P < .05); feeding 19.3 mg/kg improved these measurements by 3.0 and 3.8%, respectively. Overall incidence (score 0 vs score 1, 2, and 3) and severity (score 0, 1, and 2 vs score 3) of liver abscesses were reduced (P < .01) by feeding virginiamycin at either 19.3 or 27.6 mg/kg. Linear plateau modeling indicated that the effective dose range for virginiamycin in feedlot diets (DM basis) was 19.3 to 27.3 mg/kg for increasing average daily gain, 13.2 to 19.3 mg/kg for improving feed conversion, and 16.5 to 19.3 mg/kg for reducing liver abscess incidence.
Topics: Animals; Cattle; Cattle Diseases; Diet; Dose-Response Relationship, Drug; Eating; Female; Incidence; Linear Models; Liver Abscess; Male; Random Allocation; Severity of Illness Index; Virginiamycin; Weight Gain
PubMed: 7601759
DOI: 10.2527/1995.7319 -
Biochemistry Oct 1990Virginiamycin S (VS, a type B synergimycin) inhibits peptide bond synthesis in vitro and in vivo. The attachment of virginiamycin S to the large ribosomal subunit (50S)...
Virginiamycin S (VS, a type B synergimycin) inhibits peptide bond synthesis in vitro and in vivo. The attachment of virginiamycin S to the large ribosomal subunit (50S) is competitively inhibited by erythromycin (Ery, a macrolide) and enhanced by virginiamycin M (VM, a type A synergimycin). We have previously shown, by fluorescence energy transfer measurements, that virginiamycin S binds at the base of the central protuberance of 50S, the putative location of peptidyltransferase domain [Di Giambattista et al. (1986) Biochemistry 25, 3540-3547]. In the present work, the ribosomal protein components at the virginiamycin S binding site were affinity labeled by the N-hydroxysuccinimide ester derivative (HSE) of this antibiotic. Evidence has been provided for (a) the association constant of HSE-ribosome complex formation being similar to that of native virginiamycin S, (b) HSE binding to ribosomes being antagonized by erythromycin and enhanced by virginiamycin M, and (c) a specific linkage of HSE with a single region of 50S, with virtually no fixation to 30S. After dissociation of covalent ribosome-HSE complexes, the resulting ribosomal proteins have been fractionated by electrophoresis and blotted to nitrocellulose, and the HSE-binding proteins have been detected by an immunoenzymometric procedure. More than 80% of label was present within a double spot corresponding to proteins L18 and L22, whose Rfs were modified by the affinity-labeling reagent. It is concluded that these proteins are components of the peptidyltransferase domain of bacterial ribosomes, for which a topographical model, including the available literature data, is proposed.
Topics: Affinity Labels; Antibody Formation; Base Sequence; Binding Sites; Immunoglobulins; Molecular Sequence Data; Peptidyl Transferases; Ribosomal Proteins; Ribosomes; Succinimides; Virginiamycin
PubMed: 2125475
DOI: 10.1021/bi00491a014 -
Applied and Environmental Microbiology Sep 2005The extent of transfer of antimicrobial resistance from agricultural environments to humans is controversial. To assess the potential hazard posed by streptogramin use...
The extent of transfer of antimicrobial resistance from agricultural environments to humans is controversial. To assess the potential hazard posed by streptogramin use in food animals, this study evaluated the effect of virginiamycin exposure on antimicrobial resistance in Enterococcus faecium recovered from treated broilers. Four consecutive broiler feeding trials were conducted using animals raised on common litter. In the first three trials, one group of birds was fed virginiamycin continuously in feed at 20 g/ton, and a second group served as the nontreated control. In the fourth trial, antimicrobial-free feed was given to both groups. Fecal samples were cultured 1 day after chickens hatched and then at 1, 3, 5, and 7 weeks of age. Isolates from each time point were tested for susceptibility to a panel of different antimicrobials. Quinupristin/dalfopristin-resistant E. faecium appeared after 5 weeks of treatment in trial 1 and within 7 days of trials 2 to 4. Following removal of virginiamycin in trial 4, no resistant isolates were detected after 5 weeks. PCR failed to detect vat, vgb, or erm(B) in any of the streptogramin-resistant E. faecium isolates, whereas the msr(C) gene was detected in 97% of resistant isolates. In an experimental setting using broiler chickens, continuous virginiamycin exposure was required to maintain a stable streptogramin-resistant population of E. faecium in the animals. The bases of resistance could not be explained by known genetic determinants.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Bacterial Proteins; Chickens; Drug Resistance, Bacterial; Enterococcus faecium; Food Microbiology; Microbial Sensitivity Tests; Streptogramins; Virginiamycin
PubMed: 16151077
DOI: 10.1128/AEM.71.9.4986-4991.2005 -
Drugs 1996Most Gram-positive organisms are highly susceptible to the streptogramin, quinupristin/dalfopristin (RP 59500; Synercid). Minimum inhibitory concentrations for 90% of... (Review)
Review
Most Gram-positive organisms are highly susceptible to the streptogramin, quinupristin/dalfopristin (RP 59500; Synercid). Minimum inhibitory concentrations for 90% of isolates (MIC90) were < or = 1 mg/L for Staphylococcus aureus, S. epidermidis, S. haemolyticus, Streptococcus pneumoniae, S. pyogenes and Listeria monocytogenes. Importantly, quinupristin/dalfopristin shows similar activity against methicillin-susceptible and -resistant strains of S. aureus, and streptococci with benzylpenicillin (penicillin G)- or erythromycin-acquired resistance. Enterococci have varying susceptibility to quinupristin /dalfopristin, although most isolates tested are susceptible to the drug, including vancomycin-resistant and multiresistant Enterococcus faecium. E. faecalis are generally the least susceptible. Among the Gram-negative respiratory pathogens Moraxella catarrhalis is susceptible and Haemophilus influenzae is moderately susceptible to quinupristin/ dalfopristin; however, Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. are resistant. The drug is active against anaerobic organisms tested, including Clostridium perfringens, Lactobacillus spp., Bacteroides fragilis and Peptostreptococcus. Synergy has been demonstrated in vancomycin-resistant and multiresistant E. faecium, and methicillin-sensitive and -resistant S. aureus with the combination of vancomycin and quinupristin/ dalfopristin. Quinupristin/dalfopristin shows antibacterial activity in vivo in animal models of infection, including methicillin-sensitive and -resistant S. aureus infection in rabbits, S. aureus and S. pneumoniae in mice, and erythromycin-sensitive and -resistant viridans group streptococci infections in rats. The drug is rapidly bactericidal against Gram-positive organisms (with the exception of enterococci) at concentrations similar to or within 4-fold of the MIC, and it has a long postantibiotic effect both in vitro and in vivo.
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Virginiamycin
PubMed: 8724814
DOI: 10.2165/00003495-199600511-00007